WEE1 is a conserved protein tyrosine kinase that inhibits CDK activity and restrains the G2/M transition. The horse protein closely matches full-length human WEE1 across both regulatory and catalytic regions, supporting nuclear checkpoint activity. It is distinct from the WEE2 paralog associated with oocyte meiotic regulation.
Summary: The intact WEE1 kinase retains nucleotide/cofactor-dependent catalysis.
Reason: Full-length conservation includes the kinase domain and ATP-binding/catalytic sites, supporting these biochemical requirements independently of electronic label agreement.
Summary: The intact WEE1 kinase retains nucleotide/cofactor-dependent catalysis.
Reason: Full-length conservation includes the kinase domain and ATP-binding/catalytic sites, supporting these biochemical requirements independently of electronic label agreement.
purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected.
file:HORSE/WEE1/WEE1-bioinformatics/RESULTS.md
share 95.4% identity among 646 paired residues.
GO:0004674 protein serine/threonine kinase activity
IEA GO_REF:0000120
MODIFY
Summary: The established WEE1 substrate specificity is tyrosine phosphorylation.
Reason: These electronic assignments appear to inherit Ser/Thr-family fold terminology. The close human ortholog directly phosphorylates CDK1 Tyr15, not Thr14. Replace with the established physiological tyrosine activity; this does not claim every possible in-vitro serine autophosphorylation reaction has been excluded.
Summary: The intact WEE1 kinase retains nucleotide/cofactor-dependent catalysis.
Reason: Full-length conservation includes the kinase domain and ATP-binding/catalytic sites, supporting these biochemical requirements independently of electronic label agreement.
Summary: The established WEE1 substrate specificity is tyrosine phosphorylation.
Reason: These electronic assignments appear to inherit Ser/Thr-family fold terminology. The close human ortholog directly phosphorylates CDK1 Tyr15, not Thr14. Replace with the established physiological tyrosine activity; this does not claim every possible in-vitro serine autophosphorylation reaction has been excluded.
These computational predictions are reviewed separately from the GOA annotation set used for this review. The assessments below are from this project and do not constitute official GO annotations or endorsement by GO/UniProt. They are not included in the existing annotation review above.
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: WEE1 is a conserved CDK-inhibitory kinase, but mammalian oocyte studies distinguish somatic WEE1 from WEE2/Wee1B. A mitotic checkpoint mechanism does not automatically establish regulation of meiosis I. Broad meiotic participation cannot be excluded without horse-specific expression and perturbation evidence. Later Wee2 knockout mice retain fertility, reinforcing that this evidence should not be generalized to absolute indispensability or absence of compensation.
Supporting Evidence:
PMID:7743995: "WEE1Hu plays a role in inhibiting mitosis before M phase by phosphorylating cyclin B1-Cdc2."
PMID:21454751: "Wee1B mRNA was continuously expressed during the meiotic cell cycle and was replaced by somatic Wee1 (hereafter termed Wee1A) during the 2- or 4-cell embryo mitotic divisions"
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: Human experiments place the soluble checkpoint kinase in the nucleus. Full-length horse sequence conservation supports nucleoplasmic activity; this is more specific than the frozen horse nucleus annotation.
Supporting Evidence:
PMID:8348613: "the human wee1-like tyrosine kinase is a nuclear protein that ensures the completion of DNA replication prior to mitosis"
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: The characterized WEE1 checkpoint pool is nuclear, with additional cytoplasmic annotations. No primary evidence retrieved establishes plasma-membrane recruitment of the selected horse protein. A soluble kinase can associate peripherally with a membrane, so absence of a transmembrane helix does not refute the prediction.
Supporting Evidence:
PMID:8348613: "the human wee1-like tyrosine kinase is a nuclear protein that ensures the completion of DNA replication prior to mitosis"
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: The mouse egg-activation experiment distinguishes WEE2/Wee1B depletion, which blocks pronucleus formation, from WEE1/Wee1A depletion, which does not in that assay. The selected horse sequence is a close full-length WEE1 match, making paralog transfer a plausible explanation. However, differential necessity does not exclude participation, and later Wee2 knockout mice retain substantial fertility with possible compensation. Without horse oocyte expression and perturbation evidence, this specific biological-process prediction remains uncertain rather than definitively refuted.
Supporting Evidence:
PMID:21454751: "Wee1B knockdown oocytes failed to form pronuclei, whereas oocytes injected with control, Myt1, or Wee1A MO were correctly activated"
PMID:21454751: "Wee1B mRNA was continuously expressed during the meiotic cell cycle and was replaced by somatic Wee1 (hereafter termed Wee1A) during the 2- or 4-cell embryo mitotic divisions"
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: Protein phosphorylation follows directly from the conserved WEE1 tyrosine-kinase reaction. This is correct but broad relative to its specific CDK-inhibitory mechanism.
Supporting Evidence:
PMID:8428596: "purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected."
GO:0042327 positive regulation of phosphorylationGO_BP
UNC β Uncertain Review score: 1/2
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: WEE1 catalyzes inhibitory CDK phosphorylation, which supports protein phosphorylation. A separate positive-regulation-of-phosphorylation process requires identifying the regulated reaction; the direct catalytic reaction alone does not establish that regulatory relationship, and effects on downstream CDK phosphorylation are inhibitory.
Supporting Evidence:
PMID:8428596: "purified human Wee1 phosphorylates p34cdc2 exclusively on Tyr15 in vitro; no Thr14 phosphorylation was detected."
PMID:7743995: "WEE1Hu plays a role in inhibiting mitosis before M phase by phosphorylating cyclin B1-Cdc2."
Prediction method: ProtNLM2 Β· Version: UniProt API snapshot 2026-09-08
Review rationale: Mammalian studies identify WEE2/Wee1B as the oocyte-enriched paralog, whereas this horse sequence is WEE1. The broad female-meiosis term is not validated by conserved kinase activity alone. Redundancy and species-specific expression leave possible participation unresolved rather than proving absence. Later Wee2 knockout mice retain fertility, reinforcing that this evidence should not be generalized to absolute indispensability or absence of compensation.
Supporting Evidence:
PMID:21454751: "Wee1B mRNA was continuously expressed during the meiotic cell cycle and was replaced by somatic Wee1 (hereafter termed Wee1A) during the 2- or 4-cell embryo mitotic divisions"
PMID:21454751: "Wee1B knockdown oocytes failed to form pronuclei, whereas oocytes injected with control, Myt1, or Wee1A MO were correctly activated"